Prot #EHP-101-SS01: A Phase IIa, Double-Blind, Randomised, Intracohort Placebo-Controlled, Multicentre Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of EHP-101 in Patients with Diffuse Cutaneous Systemic Sclerosis

Project: Research project

Project Details

StatusActive
Effective start/end date1/5/211/5/24

Funding

  • Quintiles, Inc. (Prot #EHP-101-SS01)
  • Emerald Health Pharmaceuticals Australia Pty Ltd. (Prot #EHP-101-SS01)